¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ [ÃֽŠ¿¬±¸µ¿Çâ] ÀÓ»óÀÇÇÐºÐ¾ß 19¡¯ 6¿ù Å°¿öµå ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

ÃֽŠÀÇ°úÇР ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 6¿ù Å°¿öµå ºÐ¼®

 

 

2019³â 6¿ù ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇÏ¿© ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ´Â ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇко߸¦ Æ÷ÇÔÇÏ¿© 6°³ ºÐ¾ßÀÇ Å°¿öµå ºÐ¼®À» ¼öÇàÇÏ¿´´Ù. Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿¡¼­ ÃßÃâµÈ ³í¹®À» ¹ÙÅÁÀ¸·Î Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2019³â 6¿ù¿¡ ¹ßÇ¥ÇÑ ±¹³» Àú³Î ³í¹®°ú ¹Ì±¹ ±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´´Ù. Àüü 3,274Æí Áß¿¡¼­ ÀÓ»óÀÇÇко߿¡ ÇØ´çÇÏ´Â ³í¹®Àº 1,549ÆíÀ¸·Î ÀüüÀÇ 47.3%¸¦ Â÷ÁöÇÏ¿´À¸¸ç À̸¦ 5¿ù(n=1,545)°ú ºñ±³ÇÏ¿© º¼ ¶§ Å« Â÷À̸¦ ³ªÅ¸³»Áö ¾Ê¾Ò´Ù. 

 

6¿ù ÀÓ»óÀÇÇкоßÀÇ ±¹³» ±¹¿Ü ³í¹®¹ßÇ¥ ÀúÀÚ°¡ ÀÔ·ÂÇÑ Å°¿öµå¸¦ ±âº»À¸·Î ÇÏ¿© ºÐ¼®ÇÑ °á°ú´Â AMP-Activated Protein Kinases, Area Under Curve, BMI, Chronic Obstructive Lung Disease, DNA, Electroencephalography, End-Stage Kidney Disease, female, Interleukin-6, LC-MS, MicroRNAs, Nutrition Surveys, Ovarian cancer, PET, Polymerase Chain Reaction, Prostaglandins A, RNA, Serum, Side effects, Stability µîÀÇ Å°¿öµå°¡ »óÀ§·Î ÃâÇöÇÏ¿´´Ù. ÀÓ»óÀÇÇÐºÐ¾ß 6¿ù Å°¿öµå ¿¬±¸µ¿ÇâºÐ¼®Àº Çѱ¹ ¿¬±¸ÀÚ°¡ ¹ßÇ¥ÇÑ KMbase (Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º) ±âÁØÀ¸·Î  ±¹³» Àú³Î¹ßÇ¥ 822Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed ±âÁØ) 727ÆíÀ¸·Î ÃÑ 1,549ÆíÀÌ ºÐ¼®´ë»óÀ¸·Î ÀÌ¿ëµÇ¾ú´Ù. 




 

   ±×¸² 1. Çѱ¹ÀÇ°úÇÐ ¿¬±¸µ¿ÇâºÐ¼® : ÀÓ»óÀÇÇÐ ºÐ¾ß 6¿ù Å°¿öµåµ¿Çâ 





 

 Ç¥ 1.  ÀÇ°úÇÐ ÃֽŠ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 6¿ù ¿¬±¸µ¿Ç⠺м®

(KMbase: Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º 2019³â 5¿ù ±¹³»,±¹¿ÜÀú³Î ¹ßÇ¥±âÁØ n=1,549)

Å°¿öµå ¼øÀ§

ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ Å°¿öµå

1

Side effects

2

PET

3

BMI

4

Female

5

DNA

6

Area Under Curve

7

End-Stage Kidney Disease

8

Chronic Obstructive Lung Disease

9

Interleukin-6

10

Serum

11

Nutrition Surveys

12

LC-MS

13

AMP-Activated Protein Kinases

14

Electroencephalography

15

ovarian cancer

16

Prostaglandins A

17

Stability

18

RNA

19

Polymerase Chain Reaction

20

MicroRNAs

 

 


2019-07-15 ¿ÀÈÄ 6:18:33, Á¶È¸¼ö : 1461